Baxter International (BAX)
(Delayed Data from NYSE)
$39.23 USD
+1.11 (2.91%)
Updated Mar 24, 2023 04:00 PM ET
After-Market: $39.22 -0.01 (-0.03%) 7:58 PM ET
5-Strong Sell of 5 5
B Value B Growth B Momentum B VGM
Fundamental Charts
About PE Ratio (TTM)
Baxter International Inc. has a trailing-twelve-months P/E of 10.89X compared to the Medical - Products industry's P/E of 18.38X.
Price to Earnings Ratio or P/E is price / earnings. It is the most commonly used metric for determining a company's value relative to its earnings. In this example, we are using the actual earnings (EPS) for the trailing twelve months (or TTM). A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its trailing twelve months earnings. In general, a lower number or multiple is usually considered better than a higher one.
BAX 39.23 +1.11(2.91%)
Will BAX be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for BAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BAX
Baxter (BAX) Q4 Earnings Miss Estimates, FY23 Outlook Weak
Baxter International (BAX) Lags Q4 Earnings Estimates
BAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Quipt Home Medical Corp. (QIPT) to Report Q1 Results: Wall Street Expects Earnings Growth
Earnings Preview: Baxter International (BAX) Q4 Earnings Expected to Decline
Baxter (BAX) to Report Q4 Earnings: What's in the Cards?
Other News for BAX
Dividend Champion, Contender, And Challenger Highlights: Week Of March 26
Baxter International Inc. stock outperforms competitors on strong trading day
May 5th Options Now Available For Baxter International (BAX)
Tracking Al Gore`s Generation Investment Management Portfolio - Q4 2022 Update
Baxter International Inc. stock falls Thursday, underperforms market